Orphan Drugs: Medications for rare diseases often have limited patient pools, leading to high prices to recoup development costs.
Cancer Therapeutics: Innovative cancer drugs, especially those involving personalized medicine
Gene Therapies: As cutting-edge treatments for genetic disorders, these can be incredibly costly due to their novel technology and the high cost of development.
Hepatitis C Treatments: Highly effective but expensive, these drugs could become pricier if demand increases or newer, more effective versions are developed.
HIV Medications: Long-term treatments that are essential for patients, with newer formulations potentially commanding higher prices.
Insulin: A life-saving drug for diabetics, with prices historically subject to significant increases in some regions due to manufacturing complexities and market dynamics.
Biologic Drugs for Autoimmune Diseases: Drugs for conditions like rheumatoid arthritis and psoriasis are often expensive and may see further price increases.
Antidepressants: Newer or more effective formulations might command higher prices, especially if they offer advantages over existing treatments.
EpiPens and Other Emergency Medications: Essential for life-threatening situations, any innovations or supply issues could drive prices up.
Asthma Inhalers: With a constant demand and potential for new, more effective treatments, prices could rise.